Your session is about to expire
← Back to Search
Buntanetap for Early Parkinson's Disease
Study Summary
This trial is testing a new drug for early Parkinson's disease to see if it is safe and effective. There will be 5 in-clinic visits and 7 phone calls over the course of 7-8 months.
- Parkinson's Disease
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 1 & 2 trial • 75 Patients • NCT04524351Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have an intrauterine device (IUD).Both fallopian tubes are blocked.You are between 40 and 85 years old.Your memory and thinking skills are good, and you can take care of yourself without help from someone else.You are using an intrauterine hormone-releasing system.You have been diagnosed with Parkinson's disease according to specific clinical criteria.You have a history of severe mental disorders like schizophrenia, bipolar disorder, or major depression, as defined by the DSM. However, if you have mild depression and are on stable treatment with certain medications, you may still be eligible.It's okay if you have a history of seizures but only if you are taking medicine for it and your condition is stable.You have a history of heart rhythm problems or a long QT interval on an EKG test.Your heart beats too slowly or too quickly on the screening test.Your diabetes is not well controlled, or your HbA1c levels are higher than 7.5%.You need to score between 22-30 on a memory and thinking test and be able to live on your own without needing someone to help you.You are currently taking medications that affect the way your body processes other drugs.You have been diagnosed with Parkinson's disease based on specific medical criteria.Your score for how Parkinson's disease affects your movement is between 1 and 3 during the day, and you experience symptoms for less than 2 hours each day when your medication is not working.You are between 40 and 85 years old.You have not had thoughts of hurting yourself or tried to hurt yourself in the last month according to a specific assessment.You can still participate if you are taking standard medication for Parkinson's, epilepsy, mood stabilization, or neuropathic pain.You have a serious problem with your kidneys or liver.Your recent lab tests show significant problems with your liver or other important values. If your liver function tests are more than twice the normal limit, you cannot participate.You are at risk of hurting yourself or someone else, according to the doctors.You have had a serious problem with alcohol or drugs in the past 5 years.People who have trouble learning or have delays in their development.You have had cancer within the past year, except if you had treatment that could potentially cure it and there is no sign of it coming back. If you have stable untreated prostate cancer or skin cancers, you are not excluded.
- Group 1: 10 mg buntanetap/posiphen
- Group 2: 20 mg buntanetap/posiphen
- Group 3: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the mortality rates associated with Buntanetap use?
"Buntanetap's safety has been well studied in both preclinical and clinical settings, so it received a score of 3."
Are patients who are 80 years or younger being accepted for this clinical trial?
"According to the listed eligibility requirements, people aged 40 to 85 are qualified to apply for this trial. In contrast, there are 29 trials geared towards people under 18 and 512 trials for those over 65."
Are patient volunteers being accepted for this experiment right now?
"Yes, this trial is still recruiting according to the latest information available on clinicaltrials.gov. The study was originally posted on August 3rd, 2022 and has since been updated October 28th of the same year."
What are investigators hoping to study and discover through this trial?
"The primary objective of this trial is to assess safety and tolerability through physical examinations, vital signs, clinical laboratory values, 12-lead ECG, use of concomitant medications, and AE reports. Secondary objectives include assessing the MDS-Unified Parkinson's disease Rating Scale Total Score, Change on Clinical Global Impression of Severity (OFF-state), and Percentage of Responders with "Much Improved" or "Very Much Improved" on Participant Global Impression of Change (ON-state)."
Who else is applying?
How old are they?
What portion of applicants met pre-screening criteria?
What state do they live in?
What site did they apply to?
Share this study with friends
Copy Link
Messenger